Skip to content

Pain Neuroscience Education for Older Adults

Pain Neuroscience Education for Older Adults With Pain From Primary Care: a Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04528160
Enrollment
24
Registered
2020-08-27
Start date
2018-04-01
Completion date
2020-10-01
Last updated
2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

This study aims to investigate the feasibility of using pain neuroscience education for older adults with chronic pain from primary care services. It will have a group of participants receiving pain neuroscience education and exercise and a group receiving usual care.

Interventions

PNE will be conducted in line with international guidelines and will cover the neurophysiology of pain, transition from acute to chronic pain and the nervous system ability to modulate the pain experience. Exercise will included genera exercise delivered at moderate intensity.

OTHERUsual Care

Usual care delivered at primary care for older adults with pain.

Sponsors

Aveiro University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* be able to read and write and have chronic pain (defined as pain lasting 3 months or more and felt at least once a week during these 3 months ) anywhere in the body.

Exclusion criteria

* presence of pathology of the nervous or cardiovascular systems, cancer, or having had a surgery in the last 6 months or the presence of a condition for which the practice of therapeutic exercise could be contraindicated.

Design outcomes

Primary

MeasureTime frameDescription
Inclusion rate9 weeksratio between the number of participants included in the study and the total number of people contacted
Refusal rate9 weeksratio between the number of individuals who refused to participate in the study and the number of individuals contacted
Exclusion rate9 weeksratio between the number of individuals excluded for not meeting the inclusion criteria and the total number of individuals contacted
Dropout rate9 weeksratio between the number of participants who abandoned the study and the number of participants who completed the initial assessment
Retention rate9 weeksratio between the number of participants who completed the final assessment and the number of participants who completed the initial assessment
Number of participants reporting adverse events9 weeksSelf-report of any adverse event perceived as being related to the intervention
Perception of participants towards the intervention structure and content9 weeksSemi-structured interviews with participants on the structure and content of the intervention

Secondary

MeasureTime frameDescription
Pain severity and interferenceBaselineAssessed using the Brief Pain Inventory questionnaire (range 0-110 and higher values are indicative of higher pain severity and interference)
Pain catastrophizingBaselineAssessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)
DepressionBaselineAssessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)
Fear of movementBaselineAssessed using the TAMPA Scale, which assesses fear of movement (range: 13-52 and higher values are indicative of higher levels of fear of movement)
Knowledge of pain neuroscienceBaselineAssessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)
Gait velocityBaselineAssessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters
Postural controlBaselineAssessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.
Self-perceived disabilityBaselineassessed using the World Health Organization Disability Assessment Schedule 2.0 - 12-item version of WHODAS 2.0) questionnaire (range: 12-60 and higher values are indicative of higher levels of disability)
Perception of change9 weeksAssessed using the Global Perception of Change scale (answer is given using a 7-point likert scale from 1- no change to 7 - a great deal better and a considerable improvement that has made all the difference)

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026